Published in
Elsevier, The Lancet Oncology, 6(20), p. 849-861, 2019
DOI: 10.1016/s1470-2045(19)30027-0
Links
Tools
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
Journal article published in 2019 by
Cathy Eng 
,
Tae Won Kim,
Johanna Bendell,
Guillem Argilés,
Niall C. Tebbutt,
Maria Di Bartolomeo ,
Alfredo Falcone,
Marwan Fakih,
Mark Kozloff,
Neil H. Segal,
Alberto Sobrero,
Yibing Yan,
Ilsung Chang,
Anne Uyei,
Louise Roberts
and other authors.
,
Tae Won Kim,
Johanna Bendell,
Guillem Argilés,
Niall C. Tebbutt,
Maria Di Bartolomeo ,
Alfredo Falcone,
Marwan Fakih,
Mark Kozloff,
Neil H. Segal,
Alberto Sobrero,
Yibing Yan,
Ilsung Chang,
Anne Uyei,
Louise Roberts
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 